The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
Clinical trial NCT06592287 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06592287
- Sponsor
- Xianglin Yuan
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2025-09-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.